CRINETICS PHARMACE
(22663K107)
ファンドの報告 CRINETICS PHARMACE 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| VIVO Capital LLC | 3,375,169 | $84,379k | Jun 30, 2019 | Aug 13, 2019 | |
| Orbimed Advisors LLC | 2,039,282 | $50,982k | Jun 30, 2019 | Aug 14, 2019 | |
| RA Capital Management LLC | 1,875,209 | $46,880k | Jun 30, 2019 | Aug 14, 2019 | |
| Eventide Asset Management LLC | 803,839 | $20,096k | Jun 30, 2019 | Aug 14, 2019 | |
| New LEAF Venture Partners LLC | 167,700 | $4,193k | Jun 30, 2019 | Aug 13, 2019 | |
| Baker BROS Advisors LP | 132,985 | $3,325k | Jun 30, 2019 | Aug 14, 2019 | |
| Polar Capital LLP | 100,000 | $2,500k | Jun 30, 2019 | Aug 14, 2019 | |
| Opaleye Management Inc | 36,000 | $900k | Jun 30, 2019 | Aug 14, 2019 | |
| First Manhattan Co | 188 | $4k | Jun 30, 2019 | Aug 16, 2019 |